|
WDR89 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.89959999531109E-08 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.59047999999107E-05 |
| Normal-vs-Stage2 |
1.119830E-03 |
| Normal-vs-Stage3 |
1.28539999977306E-07 |
| Normal-vs-Stage4 |
6.34925445552881E-12 |
| Stage1-vs-Stage2 |
8.366200E-01 |
| Stage1-vs-Stage3 |
9.967600E-02 |
| Stage1-vs-Stage4 |
1.81521000000018E-05 |
| Stage2-vs-Stage3 |
1.940850E-01 |
| Stage2-vs-Stage4 |
1.915270E-03 |
| Stage3-vs-Stage4 |
1.488320E-02 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.00769999806283E-08 |
| Normal-vs-AfricanAmerican |
3.827300E-04 |
| Normal-vs-Asian |
2.4665999999951E-05 |
| Caucasian-vs-AfricanAmerican |
7.695800E-01 |
| Caucasian-vs-Asian |
6.724600E-01 |
| AfricanAmerican-vs-Asian |
5.936400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.28849994510227E-09 |
| Normal-vs-Female |
1.85870000002364E-06 |
| Male-vs-Female |
4.787500E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.27139999999993E-05 |
| Normal-vs-Age(41-60Yrs) |
6.3830999996739E-07 |
| Normal-vs-Age(61-80Yrs) |
9.91549997664265E-09 |
| Normal-vs-Age(81-100Yrs) |
3.023700E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.300600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.270100E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.983000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.181000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.871600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.206400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.604000E-04 |
| Classical-VS-Follicular |
3.536200E-02 |
| Classical-VS-Other |
4.064400E-01 |
| Classical-VS-Normal |
2.45059999999242E-05 |
| Tall-VS-Follicular |
1.099040E-01 |
| Tall-VS-Other |
4.375400E-01 |
| Tall-VS-Normal |
3.01939995228651E-09 |
| Follicular-VS-Other |
9.185400E-01 |
| Follicular-VS-Normal |
1.24909999998923E-06 |
| Other-VS-Normal |
1.271550E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.28910000030925E-07 |
| Normal-vs-N1 |
1.17199999705164E-08 |
| N0-vs-N1 |
9.898000E-02 |
|
|
